DaekiTech

Type 2 Diabetes is a world threat, even though the market is flourishing with numerous treatment and monitoring products and services, the detection of the disease is far from ideal. Nowadays half of all diabetics remain undiagnosed, and we want to get them diagnosed early enough to prevent the consequences of diabetes.

We are developing an innovative non invasive screening device for type 2 diabetes that uses only saliva to detect the disease. Similar to a pregnancy test, it uses a lateral flow assay that indicates through visual results if there is a high risk of having or developing type 2 diabetes in minutes.

Right now we are raising £150.000 to complete our next development stage.

REQUEST INTRODUCTION USING

LINKEDIN ANGELLIST

COMPANY PEOPLE

Amanda Céspedes

Amanda Céspedes
Founder & CEO at DaekiTech

Diego Álvarez

Diego Álvarez
Chief Financial Officer

Vicente Herrera

Vicente Herrera
CTO at DaekiTech

Camilo Berrios

Camilo Berrios
COO at DaekiTech

DaekiTech

YOU MIGHT ALSO BE INTERESTED IN